Larenas–Linnemann DES et al. – Many patients receive less than recommended doses. Two areas in which to plan further research are establishment of an optimal dose–adjustment plan for missed applications and exploration of the maximum appropriate duration of immunotherapy.
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor